BiotechTube

somatotropin

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Turner Syndrome

Conditions

Turner Syndrome

Trial Timeline

May 1, 2010 → May 1, 2014

NCT ID
NCT01367834

About somatotropin

somatotropin is a pre-clinical stage product being developed by Pfizer for Turner Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT01367834. Target conditions include Turner Syndrome.

What happened to similar drugs?

3 of 8 similar drugs in Turner Syndrome were approved

Approved (3) Terminated (0) Active (5)
🔄SomatropinEli LillyPhase 3
✅HumatropeEli LillyApproved
🔄17 beta estradiolEli LillyPhase 3
🔄Somatropin + Ethinyl estradiol + Medroxyprogesterone acetateEli LillyPhase 3
✅r-hGHMerckApproved
🔄Somapacitan + Norditropin®Novo NordiskPhase 3
✅estradiolNovo NordiskApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01367834Pre-clinicalCompleted

Competing Products

10 competing products in Turner Syndrome

See all competitors
ProductCompanyStageHype Score
SomatropinEli LillyPhase 3
40
HumatropeEli LillyApproved
43
17 beta estradiolEli LillyPhase 3
40
Somatropin + Ethinyl estradiol + Medroxyprogesterone acetateEli LillyPhase 3
40
r-hGHMerckApproved
43
Somapacitan + Norditropin®Novo NordiskPhase 3
44
estradiolNovo NordiskApproved
43
Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patchNovo NordiskPhase 1
21
Lonapegsomatropin + SomatropinAscendis PharmaPhase 2
36
Somatropin (rDNA origin)IpsenPhase 3
37